Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 94.88% institutional investors, 2.39% insiders, and 2.73% retail investors. Janus henderson group is the largest institutional shareholder, holding 11.31% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Protara Therapeutics	94.88%	2.39%	2.73%
Sector	Healthcare Stocks	35.49%	11.75%	52.76%
Industry	Biotech Stocks	34.83%	11.71%	53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	5.21M	11.31%	$27.15M
Blackrock funding, inc. /de	3.39M	7.37%	$17.69M
Boxer capital	811.63K	7.11%	$1.69M
Velan capital investment management lp	2.83M	6.16%	$14.77M
Millennium management	2.83M	6.15%	$14.75M
Vanguard group	2.39M	5.66%	$12.75M
Blackstone	2.27M	4.92%	$11.80M
Sio capital management	1.97M	4.28%	$10.26M
Acorn capital advisors	1.75M	3.81%	$9.13M
Integral health asset management	1.75M	3.80%	$9.12M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	2.83M	9.25%	$14.77M
Acorn capital advisors	1.75M	2.59%	$9.13M
5am venture management	1.37M	1.98%	$7.14M
Sio capital management	1.97M	1.47%	$10.26M
Aigh capital management	1.62M	1.15%	$8.45M
Patient square capital lp	1.03M	0.95%	$5.37M
Catalio capital management, lp	580.02K	0.63%	$3.02M
Cvi	302.75K	0.54%	$629.71K
Superstring capital management lp	121.46K	0.45%	$632.79K
Integral health asset management	1.75M	0.44%	$9.12M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	2.83M	0.01%	2.08M
Aigh capital management	1.62M	1.15%	1.62M
Point72 asset management	1.15M	0.01%	1.12M
Patient square capital lp	1.03M	0.95%	1.03M
Blackrock funding, inc. /de	3.39M	0.00%	986.10K

Top Sellers

Holder	Shares	% Assets	Change
Driehaus capital management	-	-	-1.26M
Adage capital partners gp	-	-	-1.04M
Ra capital management	-	-	-1.04M
Catalio capital management, lp	580.02K	0.63%	-866.23K
Opaleye management	-	-	-855.00K

New Positions

Holder	Shares	% Assets	Change	Value
Aigh capital management	1.62M	1.15%	1.62M	$8.45M
Patient square capital lp	1.03M	0.95%	1.03M	$5.37M
Vanguard fiduciary trust	308.84K	0.00%	308.84K	$1.61M
Cvi	302.75K	0.54%	302.75K	$629.71K
Prudential financial	119.53K	0.00%	119.53K	$622.75K

Sold Out

Holder	Change
Northwestern mutual wealth management	-2.00
Srs capital advisors	-48.00
Raymond james financial	-271.00
Amalgamated bank	-1.11K
Acadian asset management	-6.31K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	112	4.67%	43,683,816	9.71%	94	1.07%	72	-4.00%	24	50.00%
Dec 31, 2025	44	-46.99%	9,253,946	-64.69%	21	0.57%	28	-22.22%	10	-61.54%
Sep 30, 2025	33	-59.26%	6,687,978	-77.49%	15	0.32%	18	-65.38%	8	-38.46%
Jun 30, 2025	81	28.57%	29,714,883	6.28%	70	1.49%	53	65.63%	14	16.67%
Mar 31, 2025	64	-	28,759,849	-3.07%	70	0.40%	33	-26.67%	12	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.54M	2.85%	-
iShares Russell 2000 ETF	1.17M	2.13%	9.92K
Vanguard US Total Market Shares ETF	616.30K	1.74%	-
Vanguard Institutional Extnd Mkt Idx Tr	522.15K	0.97%	161.58K
iShares Russell 2000 Value ETF	430.70K	0.78%	2.32K
Fidelity Small Cap Index	346.17K	0.63%	4.10K
A4Investments SICAV SIF ACCI IlanaA2EURH	125.00K	0.61%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	302.00K	0.55%	-
CREF Stock R3	180.21K	0.47%	120.69K
Vanguard Russell 2000 ETF	252.03K	0.47%	76.75K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 08, 2026	Zummo Jacqueline	Chief R&D Officer	Sell	$6.12K
Apr 01, 2026	Zummo Jacqueline	Chief R&D Officer	Sell	$118.87K
May 14, 2025	Levy Richard S	-	Buy	$63.80K
Mar 26, 2025	Zummo Jacqueline	Chf Scientific Operations Off	Sell	$96.14K
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$2.74K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	2
2026 Q1	-	-
2025 Q2	1	-
2025 Q1	-	1
2024 Q3	-	18

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 94.88%, followed by 2.39% insiders and 2.73% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 34.83%, which Protara Therapeutics exceeds.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Janus henderson group (5.21M shares, 11.31%), Blackrock funding, inc. /de (3.39M shares, 7.37%), and Boxer capital (811.63K shares, 7.11%). Together, they hold 25.79% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.25% of its assets in 2.83M Protara Therapeutics shares, valued at 14.77M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 2.85% of its total shares outstanding invested in 1.54M Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools